期刊文献+

糖尿病患者幽门螺杆菌感染情况及颈动脉粥样硬化相关因素研究 被引量:16

Helicobacter Pylori Infection in Patients with Diabetes Mellitus and the Related Factors of Carotid Atherosclerosis
下载PDF
导出
摘要 目的探讨糖尿病(DM)患者幽门螺杆菌(H.pylori)感染情况及DM患者颈动脉粥样硬化(CAS)的相关因素。方法选取227例DM患者及436例正常对照者,对其H.pylori感染情况进行比较;DM组以是否有CAS分为CAS组和非CAS组,测量患者血压、血脂,了解吸烟、H.pylori感染情况,分析DM患者CAS相关因素。结果DM组H.pylori感染率(63.78%)高于对照组(52.06%),差异有统计学意义(P<0.05)。CAS组H.pylori感染率、男性患者比例、吸烟率、年龄、收缩压(SBP)、舒张压(DBP)、总胆固醇(TC)、三酰甘油(TG)水平高于非CAS组,高密度脂蛋白胆固醇(HDL-C)水平低于非CAS组,差异均有统计学意义(P<0.05),两组饮酒情况及低密度脂蛋白胆固醇(LDL-C)水平差异无统计学意义(P>0.05)。Logistic回归分析显示,H.pylori感染、吸烟、年龄、SBP、TG、HDL-C与DM患者发生CAS有相关性,HDL-C为保护性因素。结论 DM患者H.pylori感染率高于正常人群,H.pylori感染、吸烟、年龄、SBP、TG、HDL-C与DM患者发生CAS有相关性,应重视H.pylori感染,予以积极治疗。 Objective To explore the helicobacter pylori(H.pylori)infection in patients with diabetes mellitus(DM)and to analyze the related factors of carotid atherosclerosis.Methods Totally 227 patients with DM and 436 healthy controls were included in our study,and the H.pylori infections were detected.DM groups was divided into carotid atherosclerosis(CAS)group and non-CAS group,we assessed the related factors of CAS in DM patients including blood pressure,blood fat,smoking and H.pylori infection.Results The H.pylori infection rate in DM group(63.78%)was significantly higher than that in control group(52.06%).The patients in CAS group had statistically higher age,smoking rate,H.pylori infection rate,systolic blood pressure(SBP),diastolic blood pressure(DBP),total cholesterol(TC),triglyceride(TG)and more males as compared with those in non-CAS group,while high density lipoprotein cholesterol(HDL-C)was significantly lower than non-CAS group.There was no difference in alcohol consumption and low density lipoprotein cholesterol(LDL-C)between the two groups.Logistic regression analysis showed that H.pylori infection rate,smoking,age,SBP,TG,HDL-C were correlated with CAS in DM group,while HDL-C as a protective factors.Conclusion H.pylori infection rate in DM patients is higher than that in healthy individuals,and H.pylori infection rate,smoking,age,SBP,TG,and HDL-C can influence the development of CAS in DM patients.
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第17期1914-1916,共3页 Chinese General Practice
关键词 糖尿病 螺杆菌 幽门 动脉粥样硬化 Diabetes mellitus Helicobacter pylori Atherosclerosis
  • 相关文献

参考文献15

  • 1Yang WY, Lu JM, Weng JP, et al. Prevalence of diabetes among men and women in China [J]. N Engl J Med, 2010, 362 (12) : 1090 - 1110.
  • 2Gulcelik NE, Kaya E, Demirbas B, et al. Helicobacter pylori preva- lence in diabetic patients and its relationship with dyspepsia and auto-nomlc neuropathy [J]. Endocrinol Invest, 2005, 28: 214-217.
  • 3Ayada K, Yokota K, Kobayashi K, et al. Chronic infections and ath- erosclerosis [J]. Clin Rev Allergy Immunol, 2009, 37 (1): 44- 48.
  • 4王春江,葛伏林.幽门螺杆菌诊断方法评价[J].医学与哲学(B),2009,30(9):8-10. 被引量:3
  • 5何周桃,谢贤和,韦红,蓝程.幽门螺旋杆菌5种检测方法比较[J].临床荟萃,2011,26(7):570-574. 被引量:19
  • 6严颂琴,谌剑飞,田贺暖,谭薇,井辉.2型糖尿病患者与幽门螺杆菌感染的关系研究[J].实用糖尿病杂志,2008,4(4):21-22. 被引量:4
  • 7Stanciu OG, Trifan A, Sfarti C, et al. Helicobacter pylori infection in patients with diabetes mellitus [ J ]. Rev Med Chir Soc Med Nat Iasi, 2003, 107: 59-65.
  • 8Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastro intestinal symptoms associated with diabetes mellitus: a population based survey of 15, 000 adults [J]. Arch Intern Med, 2001, 161 (16): 1989- 1996.
  • 9Manle S, Lombardo L, Rossi C, et al. Helicobacter pylori infection and gastric function in primary autonomic neuropathy [ J]. Clin Auton Res, 2002, 12 (3): 193-196.
  • 10陈良苗,卢学勉,杨虹,叶成夫,杨士桂.2型糖尿病下肢血管病变患者的幽门螺旋杆菌感染分析[J].现代实用医学,2009,21(12):1280-1282. 被引量:9

二级参考文献69

共引文献65

同被引文献136

  • 1刘春雷,王江滨.应重视糖尿病患者的幽门螺杆菌感染[J].国际消化病杂志,2007,27(1):35-38. 被引量:27
  • 2刘翠平,黎明,李彬,陈晓燕,崔丽梅,张葵,陶静,郑晓敏,吴从愿.2型糖尿病患者血清瘦素/脂联素比值与颈动脉内膜中层厚度的关系[J].中国实用内科杂志,2007,27(15):1210-1212. 被引量:39
  • 3徐娟,胡小珊.血清同型半胱氨酸与高血压及脑梗死关系的研究[J].浙江实用医学,2007,12(4):238-239. 被引量:8
  • 4周永昌,郭万学.超声医学[M]3版.北京:科学技术文献出版社,1998-1.416.
  • 5成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 6Gulcelik NE,Kaya E,Demirbas B,et al.Helicobacter pyloriprevalence in diabetic patients and its relationship with dyspep-sia and autonomic neuropathy[J].J Endocrinol Invest,2005,28(3):214-217.
  • 7Demir M,Gokturk HS,Ozturk NA,et al.Clarithromycin resis-tance and efficacy of clarithromycin-containing triple eradicationtherapy for Helicobacter pylori infection in type 2 diabetes mellituspatients[J].South Med J,2009,102(11):1116-1120.
  • 8Malfertheiner P,Megraud F,O‘Morain C,et al.Current con-cepts in the management of Helicobacter pylori infection:the Maas-tricht III Consensus Report[J].Gut,2007,56(6):772-781.
  • 9Demir M,G ktürk S,Oztürk NA,et al.Bismuth-based first-linetherapy for Helicobacter pylori eradication in type 2 diabetes melli-tus patients[J].Digestion,2010,82(1):47-53.
  • 10Ataseven H,Demir M,Gen R.Effect of sequential treatment as afirst-line therapy for Helicobacter pylori eradication in patients withdiabetes mellitus[J].South Med J,2010,103(10):988-992.

引证文献16

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部